Conmed Return on Equity

Conmed (CNMD) currently reports a ROE of 5.43%. That is below the Healthcare sector average of 29.33%. Use the charts on this page to explore Conmed's ROE history and peer comparisons.

Conmed's ROE of 5.43% is lower than the Healthcare sector average of 29.33%. That is roughly 81.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Conmed's current 5.43% should be judged against Healthcare norms (sector average: 29.33%) and against CNMD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 5.43%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.33%. From there, open related valuation or income-statement pages for Conmed, and consider following CNMD for alerts when major investors trade the stock.

Conmed is classified in the Healthcare sector. On ROE, it currently shows 5.43% versus a sector average near 29.33%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CNMD with unrelated industries.